Gene: AKR1E2
Official Full Name: aldo-keto reductase family 1 member E2provided by HGNC
Gene Summary: The protein encoded by this gene is a member of the aldo-keto reductase superfamily. Members in this family are characterized by their structure (evolutionarily highly conserved TIM barrel) and function (NAD(P)H-dependent oxido-reduction of carbonyl groups). Transcripts of this gene have been reported in specimens of human testis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25455 | AKR1E2 Knockout cell line (HCT 116) | Human | AKR1E2 | 1:2~1:4 | Negative | Online Inquiry |
KO25456 | AKR1E2 Knockout cell line (A549) | Human | AKR1E2 | 1:3~1:4 | Negative | Online Inquiry |
AKR1E2 Gene Knockout Cell Lines represent a pioneering advancement in the field of genetic engineering, specifically designed for the comprehensive study of the aldo-keto reductase (AKR) enzyme family, particularly the AKR1E2 isoform. These cell lines have been meticulously developed to exhibit a complete absence of the AKR1E2 gene, enabling researchers to investigate the physiological roles and biochemical pathways influenced by this critical enzyme in cellular contexts, particularly regarding its implications in drug metabolism, toxicology, and disease pathogenesis.
The primary function of the AKR1E2 protein is its involvement in the reduction of carbonyl compounds, a process vital for cellular detoxification and metabolism. By utilizing these knockout cell lines, scientists can elucidate the specific contributions of AKR1E2 in these processes, providing insights into how alterations in this enzyme may affect various biological outcomes, including cellular responses to oxidative stress and the biotransformation of xenobiotics.
From a scientific standpoint, these knockout cell lines are invaluable tools in both research and clinical applications. For example, they facilitate the development of pharmacogenomic profiles, allowing clinicians to tailor therapies based on how patients metabolize specific drugs influenced by AKR1E2 activity. Moreover, they can aid in the exploration of therapeutic targets for diseases where AKR dysregulation plays a significant role, such as cancer and metabolic disorders.
What sets AKR1E2 Gene Knockout Cell Lines apart from alternative products is their rigorous validation and reproducibility, ensuring that researchers obtain reliable data. The specificity of these cell lines allows for precise experimental control, significantly enhancing the robustness of findings related to AKR1E2’s functional dynamics.
Investing in AKR1E2 Gene Knockout Cell Lines is a strategic move for researchers and clinicians aiming to push the boundaries of knowledge in drug metabolism and disease mechanisms. Our company prides itself on providing high-quality, well-characterized biological products, and our expertise in genetic engineering ensures that you will receive superior tools essential for your innovative research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.